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Abstract 
The use of artificial sweeteners (ASWs) has increased and become more widespread, and consequently ASWs have 
appeared in aquatic environments around the world. However, their safety to the health of humans and wildlife 
remains inconclusive. In this study, using medaka embryos (Oryzias latipes), we investigated developmental toxicity 
of aspartame (ASP) and saccharin (SAC). Since ASWs are often consumed with caffeine (CAF) and CAF with sucrose 
(SUC), we tested biological activities of these four substances and the mixtures of CAF with each sweetener. The 
embryos were exposed to ASP at 0.2 and 1.0 mM, SAC at 0.005 and 0.050 mM, CAF at 0.05 and 0.5 mM, or SUC at 29 
and 146 mM, starting from less than 5 h post fertilization until hatch. Control embryos were treated with embryo solu‑
tion only. Several endpoints were used to evaluate embryonic development. Some of the hatchlings were also tested 
for anxiety‑like behavior with the white preference test. The results showed that all four substances and the mixtures 
of CAF with the sweeteners affected development. The most sensitive endpoints were the heart rate, eye density, and 
hatchling body length. The hatchlings of several treatment groups also exhibited anxiety‑like behavior. We then used 
the Integrated Biological Response (IBR) as an index to evaluate the overall developmental toxicity of the substances. 
We found that the ranking of developmental toxicity was SAC > CAF > ASP > SUC, and there was a cumulative effect 
when CAF was combined with the sweeteners.
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Background
Artificial sweeteners (ASWs) have been in use for dec-
ades, but they are now increasingly added to all kinds of 
foods, drinks, and pharmaceutical products. As a con-
sequence, ASWs are excreted from our bodies and dis-
charged with sewage treatment effluents to the aquatic 
environment. Therefore, they have emerged as a class of 
environmental contaminants.
For example, saccharin (SAC) is largely unmetabolized 
in human body, allowing it to pass unchanged to the envi-
ronment, mainly through the urine. It is usually degraded 
by more than 90 % during wastewater treatment (Lange 
et  al. 2012). However, wastewater is not always prop-
erly treated, and SAC concentrations may be too high to 
be efficiently removed. In a Canadian river watershed, 
SAC at a concentration of 7.2  µg/L was found where 
both urban population and the consumption of calorie-
reduced beverages were high (Spoelstra et al. 2013). Con-
centrations of SAC up to 19.7 µg/L were also found from 
surface waters in Spain (Ordóñez et al. 2012), and up to 
137 µg/L from wastewater in Singapore (Tran et al. 2013).
On the other hand, aspartame (ASP) is metabolized to 
50 % phenylalanine, 40 % aspartic acid, and 10 % metha-
nol in humans (Ranney et al. 1975). The small amount of 
methanol has been suggested to be responsible for ASP 
carcinogenicity (Soffritti et al. 2010). Because these com-
ponents are absorbed and metabolized as other foods, 
ASP is usually not detected in environmental water sam-
ples (Lange et al. 2012; Ordóñez et al. 2012). Nonetheless, 
Gan et  al. (2013) have reported its presence in surface 
waters at concentrations up to 0.21 µg/L in China.
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Unlike other contaminants, ASWs are substances we 
actively purchase and ingest regularly, sometimes in 
large quantities. Although many studies have supported 
the safety and benefits of ASWs (Weihrauch and Diehl 
2004; Marinovich et al. 2013), clear evidence of safety in 
long-term use is still lacking (Wiebe et al. 2011; Shankar 
et  al. 2013; Gardner 2014). In addition, their develop-
mental toxicity is surprisingly inconclusive. For example, 
prospective studies on pregnant women have found an 
association of daily intake of ASWs-containing beverages 
with preterm delivery (Halldorsson et al. 2010; Englund-
Ögge et al. 2012) or offspring allergic diseases (Maslova 
et al. 2013), but Marinovich et al. (2013) have also con-
cluded in their review study that ASWs were not related 
to preterm delivery.
Animal studies on developmental toxicity of ASWs 
are mostly conducted on rats and mice; studies on fish 
or aquatic organisms are scarce. Saccharin is usually 
considered safe and often used as a negative control in 
toxicological studies, such as the study conducted by 
Selderslaghs et al. (2009). But the authors actually found 
that saccharin at 55 mM induced 92 % mortality within 
24  h post fertilization in zebrafish embryos. As to ASP, 
Soffritti et  al. (2007) have conducted a study with rats 
using a dose (100 mg/kg bw/day) higher than the accept-
able daily intake value for humans (40  mg/kg bw in the 
European Union and 50 mg/kg bw in the United States). 
They found that lifespan exposure to the sweetener is car-
cinogenic, and exposures beginning from prenatal period 
further increased the risk. Abd Elfatah et al. (2012) also 
found that a high dose of ASP at 50 mg daily induced his-
tological lesions and genetic alterations in mother rats 
and their offspring. But an earlier study found no devel-
opmental effect from ASP at much higher doses of 500–
4000 mg/kg bw (McAnulty et al. 1989).
Due to the need for more information regarding devel-
opmental toxicity and ecological impact of ASWs, we 
used medaka embryos (Oryzias latipes) as a bioassay to 
tackle both issues at the same time. The fish is an ovipa-
rous freshwater teleost. It has become a popular animal 
model in recent years due to its hardiness, small size 
(adult 2–4  cm in length), high fecundity (spawn 10–20 
eggs daily), and short generational time (2–3  months). 
Most of all, as medaka embryos are transparent, their 
development can be easily observed in whole living 
embryos. These qualities have rendered the fish ideal for 
developmental toxicity studies.
Here, using medaka embryos, we investigated devel-
opmental toxicity of two ASWs, ASP and SAC, along 
with the natural sweetener sucrose (SUC) and the 
known developmental toxin-caffeine (CAF). As CAF 
was often ingested with sweeteners, the combinations 
of CAF with SUC, ASP, or SAC were tested as well. The 
concentrations used in this study were much lower than 
those of the above-mentioned studies because they were 
intended to be more realistic and environmentally rel-
evant. We also used the white preference test (Lee and 
Yang 2014) to investigate behavioral consequences of this 
developmental toxicity. Furthermore, a novel approach—
the integrated biomarker response (IBR; Beliaeff and Bur-
geot 2002; Lee and Lee 2014) was applied to evaluate the 
overall developmental toxicity of the tested substances.
Methods
Experimental animals
A colony of medaka had been established in the current 
facility for over 5  years. They were maintained at 28  °C 
under a constant 14 h light:10 h dark photoperiod in glass 
tanks filled with flow-through filtered water (pH 7.5–
7.8). Medaka embryos were incubated in embryo solu-
tion (0.1 % NaCl, 0.003 % KCl, 0.004 % CaCl2·2H2O, and 
0.016 % MgSO4·7H2O, pH 7.5–7.8). All salts in the solu-
tion were supplied by J.T.Baker (Phillipsburg, NJ, USA). 
The fish were fed three times daily with brine shrimp 
(<24 h after hatching). All procedures were carried out in 
accordance to the “Guidelines for Animal Experimenta-
tion” of Chang Jung Christian University, Taiwan.
Chemicals and test solutions
Sucrose (PA34230, purity  >  99  %) was purchased 
from Panreac (Barcelona, Spain); ASP (228650050, 
purity  >  98  %), SAC (149001000, purity  >  98  %), and 
CAF (108160100, purity > 98.5 %) were purchased from 
Acros Organics (Geel, Belgium). A 1000× stock solution 
of ASP was prepared with DD water. Stock solutions of 
SAC and CAF were prepared as 10× with embryo solu-
tion. All of the stock solutions were then diluted with 
embryo solution immediately before exposures to make 
final concentrations of ASP at 0.2 and 1  mM, SAC at 
0.005 and 0.05  mM, and CAF at 0.05 and 0.5  mM. The 
SUC test solutions were prepared at concentrations of 
29 and 146 mM. All (stock) solutions were stored at 4 °C 
and used within a month. The concentrations, abbrevia-
tions, and numbers of embryos in each group are listed 
in Table 1.
Embryo exposures
Medaka embryos from breeding pairs were collected 
within 5  h post fertilization. They were randomly 
assigned to different exposure groups, placed in 24-well 
plates, one embryo per well, and incubated at 27  °C. 
Each well contained 1 ml embryo or test solutions, which 
were replaced every 24 h. Embryos treated with embryo 
solution served as controls. To limit observation period 
within 2 h, each exposure experiment contained less than 
17 embryos (2–4 per group), and the experiment was 
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repeated 13 times. Obviously the 12 treatment groups 
could not be all tested at the same time, but the con-
trol group was always included in each experiment. The 
embryos were exposed continuously until hatch. The 
hatchlings were photographed and then transferred to 
glass dishes containing embryonic solution only.
Observations and image analysis
The procedures were as described previously (Lee et  al. 
2012). Briefly, the heart rate of embryos was first counted 
for 1  min under a dissection microscope at 27  °C, then 
the embryos were anaesthetized with 0.06 % MS222 (pH 
7.25, Sigma-Aldrich), and their images recorded under 
a microscope (IX2-SLP, Olympus, Tokyo, Japan) from 
1 to 3 days post fertilization (dpf) and at hatch. The eye 
length, width, and pigmentation density (eye density), the 
distance between the eyes (eye distance; representing the 
head growth), the width of the optic tectum (midbrain 
width), and the hatchling body length were analyzed 
from the images with ImageJ image processing and analy-
sis software (http://rsbweb.nih.gov/ij/). All images were 
obtained and analyzed under identical conditions with-
out any alteration.
White preference test
The white preference test was conducted as described 
previously (Lee and Yang 2014). Briefly, individual hatch-
ling (4 days after hatching) was held with a pipet for 30 s 
and then released in the black area of a rectangular box 
(L 60 mm × W 40 mm × H 15 mm) with two equal black 
and white areas. A square pattern of 5  ×  5  mm2 was 
drawn on the bottom surface. Once released, hatchlings 
were allowed to explore freely for 2 min. Each hatchling 
was tested once. The following endpoints of the hatchling 
movement were analyzed from the video recording: time 
lapse to white area, time spent in black or white areas, 
number of squares entered (indicating swimming dis-
tance), and time swimming along the sides or around the 
center of the box.
The integrated biomarker response (IBR)
The integrated biomarker response (IBR) was calculated 
as described previously (Beliaeff and Burgeot 2002; Lee 
and Lee 2014). Briefly, measurements from the treatment 
groups were standardized as a set of indexes, one set for 
each endpoint. An IBR value was calculated from the 
indexes of four endpoints (day to hatch, hatchling body 
length, time lapse to white area in the behavioral test, and 
total number of squares hatchlings entered in 60 s) from 
each treatment group.
Statistical analysis
The statistics software SPSS 17 (SPSS Inc., Chicago, USA) 
was used for all data analysis. One-way ANOVA was con-
ducted, followed by the LSD post hoc test to compare vari-
ables of each endpoint among the treatment groups. Values 
were considered as significantly different when P <0.05.
Results
Effects of exposures on embryonic development
Representative images of the embryos from the control and 
SAC2 groups are shown in Fig. 1, in which the SAC2-treated 
Table 1 Abbreviations and concentrations of chemicals used in this study
– not applicable
a The Human Metabolome Database, http://www.hmdb.ca/
b The DrugBank Database, http://www.drugbank.ca/
c TCI America Material Safety Data Sheet, https://www.spectrumchemical.com/MSDS/TCI-A0997.pdf
Chemical CAS number Log P LD50 (oral) Molecular 
weight
Abbreviation Concentration N
Behavior Embryonic  
development
mM mg/ml
Sucrose 57‑50‑1 −3.70a 29,700 mg/kg [Rat]a 342.3 SUC SUC1 29 10 15
SUC2 146 50 14
Aspartame 22839‑47‑0 −0.10b >10,000 mg/kg [Rat]c 294.3 ASP ASP1 0.2 0.06 15
ASP2 1.0 0.30 15
Saccharin 81‑07‑2 0.91a 17,000 mg/kg [Mouse]a 183.2 SAC SAC1 0.005 0.001 14
SAC2 0.050 0.010 14
Caffeine 58‑08‑2 −0.07a 127 mg/kg [Mouse]a 194.2 CAF CAF1 0.05 0.01 14
CAF2 0.50 0.10 14
– – – – – CAF + SUC CAF2 + SUC1 Refer to individual 
compounds
11
– – – – – CAF + ASP CAF2 + ASP1 11
– – – – – CAF + SAC CAF2 + SAC1 11
Control – – – – – – – 38
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embryo appeared to be less developed than the control. The 
responses of each endpoint are described as follows:
Heart rate
The heart rate appeared to be the most sensitive end-
point for the tested substances. At 2–3 dpf (Fig. 2; only 
data at 3 dpf were shown), most of the treatment groups 
had significantly higher heart rates than the control. 
The increases of the heart rates ranged widely, from 
7.8  % (ASP1) to 26.2  % (CAF2) at 3 dpf. In addition, 
CAF2 combined with SUC1, ASP1, and SAC1 had sig-
nificantly lower heart rate than CAF2 alone. In regard to 
dose-dependence, the pairs of SAC1/2 and CAF1/2 at 3 
dpf exhibited such an effect, with higher concentrations 
causing significantly higher heart rates.
Eye width and length
The eye width and length were not affected as much 
as the heart rate. The eye width of SUC1 increased 
significantly at 1 and 3 dpf, compared to the control, 
while that of CAF2 decreased at 2 and 3 dpf (Fig. 2; only 
data from 3 dpf were shown). However, these differences 
were small, only up to 6.3 %. A dose dependent effect was 
found between the pair of CAF1/2 at 3 dpf; CAF2 was 
5.1 % smaller than CAF1.
As to the eye length, only ASP1 at 2 dpf (not shown) 
and SAC2 at 3 dpf (Figs. 1, 2) were significantly shorter 
than the control. The groups of SAC1/2 also exhibited a 
dose-dependent effect at 3 dpf: SAC2 was 3.9 % shorter 
than SAC1.
Eye distance
The exposures did not significantly affect the eye dis-
tance until 3 dpf, when SUC2, ASP1, SAC2, CAF2, and 
CAF2 + SUC1 were significantly shorter than the control 
(Fig. 2). The differences were also small, only up to 6.9 %. 
A dose-dependent effect was found between the pairs of 
SUC1/2 and SAC1/2.
Fig. 1 Representative images of medaka embryos exposed to saccharin at 0.05 mM (SAC2) or embryo solution only (control) at 1–3 days post 
fertilization (dpf). The exposures started from less than 5 h post fertilization until hatch. The images were cropped, but their relative proportion was 
maintained. No other alteration was made. Bar 100 µm
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Midbrain width
At 1 dpf, the midbrain width of CAF1 and CAF2 increased 
14.2 and 10.7 %, respectively, compared to the control (not 
shown). But this increase disappeared at 2 dpf, and at 3 
dpf CAF2 became significantly, though only 3.3 %, shorter 
than the control (Fig. 2). The midbrain width of SAC2 was 
also significantly shorter than that of the control at 3 dpf. 
A dose-dependent effect was found between ASP1/2 at 2 
dpf (not shown), and SAC1/2 and CAF1/2 at 3 dpf.
Eye density
The SAC1 test solution significantly increased (12.9  %) 
the eye density of the exposed embryos at 3 dpf, 
compared to the control (Fig. 2). Interestingly, CAF com-
bined with all three sweeteners also raised the eye density 
significantly; the increases ranged from 12.9 to 27.5 %. A 
dose-dependent effect was found in SAC1/2; SAC2 aver-
aged 15.2 % lower than SAC1.
Day to hatch
Both SUC1 and SUC2 took 23.9 and 30.0 %, respectively, 
less time to hatch, compared to the control, but this dif-
ference was only statistically significant in SUC2 (Fig. 2). 
Conversely, the CAF2 + SUC1 and CAF2 + SAC1 groups 
took 20.3 and 26.8  %, respectively, longer time to hatch 
than the control, but these differences were not statisti-
cally significant.
Hatching rate
The groups of SAC2 and CAF1 had significantly 
lower hatching rates than the control (80.0  ±  11.1 and 
71.4 ± 13.0 %, respectively, vs. 100 %). The other groups 
were comparable to the control (Fig. 2).
Hatchling body length
The hatchlings from SAC2 and CAF2 were 4.3 and 
11.4  %, respectively, shorter than the control. Interest-
ingly, the combinations of CAF2 with the sweeteners 
caused a 7.2–11.7  % significant reduction in hatchling 
body length, compared to the control. These hatchlings 
were also significantly shorter than those exposed to 
SUC1, ASP1, or SAC1 alone (Fig. 2). A dose dependent 
effect was seen between the pairs of CAF1/2.
Effects of exposures on hatchling anxiety‑like behavior
As there was no significant difference between pairs of 
substances at different concentrations, their data were 
combined for analyses (Fig.  3). Representative record-
ings of the white preference test from the control and 
CAF + SUC hatchlings are available as Additional files 1 
and 2.
The result showed that, compared to the control 
(29.1 ± 8.9 s), most of the treatment groups took signifi-
cantly less time crossing to the white area (Fig. 3a). The 
differences of this time lapse ranged from 13.0 s (ASP at 
16.1 ± 3.6 s, p < 0.05) to 24.3 s (CAF + SUC at 4.8 ± 1.4 s, 
p < 0.01). At 15 s (Fig. 3b), CAF + SUC and CAF + ASP 
spent significantly less time in the black area (4.8 ±  1.4 
and 5.6 ± 1.5 s, respectively, vs. 10.8 ± 1.7 s, p < 0.05) and 
more time in the white area. During 15–60 s (Fig. 3c), in 
addition to CAF + SUC and CAF + ASP, the groups of 
ASP, SAC, and CAF were also significantly different from 
the control (p  <  0.05) in their time distribution in the 
black and white areas. During 60–120 s (Fig. 3d), none of 
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Fig. 2 Effects of sucrose (SUC), aspartame (ASP), saccharin (SAC), 
caffeine (CAF), and CAF combined with each sweetener on medaka 
development at 3 days post fertilization or at hatch. Data were 
percents of control values and expressed as mean ± SEM. *Signifi‑
cantly different from the control or between pairs of groups, p < 0.05; 
**p < 0.01; ***p < 0.001. The abbreviations and concentrations of the 
substances are listed in Table 1
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As to swimming distance, at 15 s (Fig. 3e), total num-
bers of squares from CAF + SUC and CAF + ASP were 
significantly higher than that of the control (10.7 ±  1.2 
and 10.1 ±  1.6, respectively, vs. 4.8 ±  1.3, p  <  0.05). At 
120 s (Fig. 3f ), CAF + SUC remained significantly higher 
than the control (107.0 ± 10.3 vs. 66.3 ± 13.4, p < 0.01), 
but not CAF + ASP. Interestingly, the hatchlings exposed 
to CAF +  ASP entered significantly more squares than 
ASP alone (90.8  ±  8.0 vs. 66.0  ±  7.0, p  <  0.05), while 
those exposed to CAF +  SUC also entered significantly 
more squares than SUC or CAF alone (107  ±  10.3 vs. 
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Fig. 3 Results of the white‑preference test from medaka hatchlings exposed to test substances during embryonic development. a Time lapse of 
the hatchlings crossing from the black to white area; b time distribution of hatchlings in the black and white areas during the first 15 s, c 15–60 s, 
and d 60–120 s; e number of squares hatchlings entered during the first 15 s and f the whole 120 s; g cumulative number of squares hatchlings 
entered during the 120 s test period; h slopes of the curves from (g). Different letters indicate significant differences, p < 0.05. Letters on the side of the 
columns in b–d are comparisons of the white areas, and those on top of the columns in e and f are comparisons of total number of squares. No letter 
was placed by the black areas in b–d because statistical analyses produced identical results to those of the white areas. In e and f, no significant 
difference was found among the black areas, while statistical analyses on the white areas produced identical results to those on the total numbers 
of squares. Values were expressed as mean ± SEM. *Significantly different from the control, p < 0.05. The abbreviations and concentrations of the 
substances are listed in Table 1
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The cumulative number of squares hatchlings entered 
during the test period was shown in Fig. 3g, which indi-
cated that CAF  +  SUC caused the highest increase 
among the groups. As shown in Fig. 3h, statistical anal-
yses on the slopes of these cumulative curves produced 
identical results to those in Fig. 3f.
Interestingly, when in the white area, the hatchlings 
spent 65.3 ± 2.9 % of the time swimming along the sides, 
but when in the black area they spent 91.6 ± 1.6 % of the 
time swimming around the center. This phenomenon was 
consistent with our previous study (Lee and Yang 2014), 
but there was no significant difference in this side/center 
preference among the groups. However, a dose depend-
ent effect was found in the pairs of SAC1/2: when in the 
white area, the SAC2 group spent significantly more time 
along the sides of the box, compared to SAC1 (70.3 ± 9.6 
vs. 49.0 ± 5.8 %, p < 0.05).
Integrated biomarker response (IBR) of the treatment 
groups
To better assess relative developmental toxicity of the 
substances, the IBRs of the treatment groups were calcu-
lated with four endpoints: day to hatch, hatchling body 
length, time lapse to white area in the behavioral test, and 
total number of squares hatchlings entered in 60 s.
As shown in Fig.  4, all of the treatment groups had 
lower IBRs than the control. The lowest values were from 
the groups of SAC1 and CAF2, only 20–21 % of the con-
trol value. In regard to dose dependence, the group of 
CAF2 had lower IBR values than CAF1, while SAC2 had 
higher IBRs than SAC1.
Lastly, to explore the possibility of producing a cumula-
tive effect when CAF was combined with the sweeteners, 
we compared the actual IBRs of the CAF mixtures with 
the sums of IBRs from each corresponding individual 
substance groups. It turned out that the values were quite 
similar, resulting in a ratio averaged 0.93 ± 0.05.
Discussion
Effects of CAF and the sweeteners on embryonic 
development
The substances of SUC, ASP, SAC, CAF, and the combi-
nations of CAF with the sweeteners all affected embry-
onic development and/or behavior, as summarized in 
Table 2.
As expected, CAF affected development in all six cat-
egories listed in Table 2. Surprisingly, all the substances 
and their combinations affected embryonic heart rates 
(SUC2 significantly increased the heart rate at 2 dpf, 
not shown in Fig.  2). In addition, the mixtures of CAF 
with the sweeteners also advanced the eye development, 
shortened the hatchling body length, and/or modified 
behavior.
Caffeine has been known to have developmental tox-
icity in fish. It had no effect at less than 0.75  mM in 
zebrafish embryos, but at 1  mM or higher it produced 
hatchlings with shorter body length (Chen et  al. 2008), 
an effect consistent with our results. Also using zebrafish 
embryos, Hermsen et  al. (2013) reported that CAF at 
0.22–1.75  mM induced scoliosis and head and heart 
malformations. Selderslaghs et al. (2009) also found that 
CAF at 0.1 mM induced higher incidences of deformed 
5.97  
2.48  
3.33  3.14  
4.06  
1.22  
3.49  3.81  
1.28  









Fig. 4 The integrated biomarker response (IBR) values of medaka hatchlings exposed to test substances during embryonic development. The 
endpoints selected were day to hatch, hatchling body length, time lapse to white area in the behavioral test, and total number of squares hatchlings 
entered in 60 s. The abbreviations and concentrations of the substances are listed in Table 1
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tails, but the hatching rate was only slightly affected. In 
our study, CAF1 (0.05 mM) caused a 29 % decrease in the 
hatching rate, but not CAF2 at 0.5 mM. In addition, no 
apparent malformation was observed from both groups. 
However, CAF2 significantly shortened the eye and mid-
brain width and hatchling body length, and raised the 
heart rates. It is likely that species differences contribute 
to the inconsistencies, and consequences of CAF bio-
logical activities vary with different concentrations and 
endpoints.
Caffeine is a known psychostimulant; it has been found 
to activate brain activity and cerebral blood flow in 
humans, and may induce anxiety in higher doses (Chen 
and Parrish 2009). Nehlig and Debry (1994) also reported 
that pregnant rats and mice ingested CAF in doses equiv-
alent to tens of cups of coffee per day produced offspring 
with altered behavior, including learning abilities and 
anxiety levels. Recently, Silva et al. (2013) demonstrated 
that female mice exposed to CAF during pregnancy and 
lactation produced offspring with increased neuronal 
network excitability, and the offspring grew up to have 
cognitive deficits.
However, Brent et al. (2011), after reviewing epidemio-
logical and animal studies, have reported that evidence 
for developmental toxicity of CAF in humans is inconclu-
sive. The authors indicated that the plasma level of CAF 
has to reach 0.3  mM to cause teratogenic effects. It is a 
level roughly equivalent to consuming more than 30 cups 
of coffee a day in humans, a fairly unlikely scenario. This 
plasma level of 0.3 mM was in-between the concentrations 
of CAF1 and CAF2 of this study. Since CAF1 at 0.05 mM 
already produced effects on medaka development, such as 
increasing the heart rate and inducing anxiety-like behav-
ior (the time lapses of CAF1 and CAF2 hatchlings moving 
to the white area were both significantly shorter than that 
of the control), apparently for subtler effects the minimum 
plasma level of CAF is likely to be lower.
Other than CAF, SAC was another substance affect-
ing all six categories (Table  2). As SAC also induced 
significant differences at much lower concentrations than 
SUC and ASP, it is likely to be more toxic than the other 
two. This is consistent with the result from a study by 
Bandyopadhyay et al. (2008), in which SAC at lower con-
centrations induced more DNA damage than ASP did in 
mouse bone marrow cells.
Though SAC at 55  mM produced 92  % mortality in 
zebrafish embryos, it caused no effect at concentrations 
up to 27.9 mM (Selderslaghs et al. 2009). In another study 
with zebrafish embryos, SAC at 10 mM did not cause any 
deformity (Hermsen et  al. 2013). In the current study, 
SAC at a much lower concentration of 0.05 mM caused 
20  % mortality, suggesting that, compared to zebrafish, 
medaka embryos were more sensitive to SAC.
Effects of SUC (or glucose) on development have been 
studied extensively. It is well-known that diabetic moth-
ers are at five-time higher risk of producing offspring 
with congenital malformation (Chappell et  al. 2009). 
Glucose exposure at 50 and 100 mM induced malforma-
tions and higher than 70 % of mortality in cultured chick 
embryos (Datar and Bhonde 2005), or impaired neuronal 
development at 25  mM in quail embryos (Chen et  al. 
2013). Furthermore, preterm infants given repeated high 
dose of sucrose were more likely to show poorer atten-
tion and motor development (Johnston et  al. 2002). In 
this study, SUC at high concentrations (29 and 146 mM) 
appeared to have a slight effect on medaka development. 
But it did not significantly affect hatchlings’ white prefer-
ence behavior, unless combined with CAF, an issue to be 
discussed in next section.
Interaction of CAF and sweeteners in anxiety‑like behavior
Our results suggest that SUC is relatively safe at high 
concentrations. But when combined with CAF, it surpris-
ingly heightened anxiety-like behavior in hatchlings. Fur-
thermore, the mixture of CAF with ASP also significantly 
raised the anxiety level.
Caffeine has been known to potentiate the reinforc-
ing effects of alcohol through adenosine and dopamine 
Table 2 Summary of biological responses in medaka embryos exposed to various substances during development
– not different from controls
√ significantly different from controls, p < 0.05
Group Heart Eye Head Brain Hatching Behavior
SUC √ √ √ – √ –
ASP √ – √ – – √
SAC √ √ √ √ √ √
CAF √ √ √ √ √ √
CAF + SUC √ √ √ – √ √
CAF + ASP √ √ – – √ √
CAF + SAC √ √ – – √ –
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neurotransmission when the two substances are com-
bined (Ferré and O’Brien 2011). Similarly, CAF has been 
linked to increased additive properties of other abused 
substances, including cocaine, nicotine, and sugar (Tem-
ple 2009). Incidentally, SUC-dependent rats have been 
shown to have altered dopamine receptors and opioid 
mRNA levels similar to those in morphine-dependent 
rats (Spangler et al. 2004). Thus, our result was consist-
ent with the notion that the interaction between CAF 
and SUC may pose a health risk to younger populations 
(Seifert et  al. 2011). However, whether this interaction 
represents a synergistic relationship would require fur-
ther studies using appropriate mixture designs.
The potential toxicity of ASP has been investigated 
extensively for decades, and so far ASP is still considered 
very safe (Butchko et al. 2002). More recent studies also 
reported no evidence supporting a risk to human health, 
including preterm deliveries (Marinovich et  al. 2013), 
nervous system function, learning, and behavior (Mag-
nuson et  al. 2007). But in our study, ASP increased the 
heart rate in medaka embryos, slightly suppressed the 
head growth, and induced anxiety-like behavior in hatch-
lings. Therefore, more studies are needed to ensure the 
safety of ASP consumption.
Cumulative effects of CAF and sweeteners
From the IBRs, we found a cumulative effect in develop-
mental toxicity when CAF is combined with the sweeteners. 
However, further studies are required to confirm the result.
Caffeine is not very soluble in water, due to its non-
polar ring structure. Consequently, the molecules tend to 
self-aggregate and stack with each other on their flat sur-
face like coins (Tavagnacco et al. 2011). In the presence 
of SUC, CAF would be drawn by a weak affinity to stack 
with SUC instead, which increases CAF solubility (Lilley 
et al. 1992). Both ASP and SAC also have ring structures, 
and they might similarly stack with CAF in solutions. 
But this is just speculation, and there is no evidence indi-
cating that this structurally stacking contributes to the 
cumulative effect of CAF with the sweeteners.
The IBR values of the SAC1 and CAF2 groups were 
the lowest among the groups, while those of ASP and 
SUC were at the similar level. Since the concentra-
tion of SAC1 was much lower than that of CAF2, and 
that of ASP1/2 was much lower than that of SUC1/2, 
the ranking of developmental toxicity should be 
SAC  >  CAF  >  ASP  >  SUC. We have also demonstrated 
that the IBR is a useful tool to evaluate developmental 
toxicity with multiple endpoints.
As the concentrations of SAC and ASP tested in this 
study were at least 10 times higher than those found in 
the environment, the health risk of these two substances 
on wildlife may be negligible. However, CAF and other 
ASWs are increasingly found in aquatic environments. 
For example, CAF and cyclamate have been found to be 
at the concentrations of 265–14,418 and 28–1406  ng/L, 
respectively, in surface water (Tran et  al. 2013). Their 
cumulative activities may amount to significant levels 
and deserve more investigations.
Conclusion
We used the medaka embryo as a model system to evalu-
ate developmental toxicity of CAF and three sweeteners: 
SUC, ASP, and SAC. Several endpoints for development 
were selected for evaluation, including the heart rate, 
eye density, time to hatch, and anxiety-like behavior. 
We found that all four substances and the mixtures of 
CAF with the sweeteners affected development and/
or behavior. We then used the IBR to better evalu-
ate the overall toxicity of these substances. The result 
showed that the ranking of developmental toxicity was 
SAC  >  CAF  >  ASP  >  SUC, and there was a cumulative 
effect when CAF was combined with the sweeteners. 
Although the concentrations we tested were higher than 
those detected from the environment, this study has 
demonstrated that ASWs may pose a health risk to both 
humans and wildlife, and the effects may accumulate to 
significant levels when CAF is combined with ASWs.
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